Search the Newsreel

InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com

InspireMD, Inc. has appointed Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. Kennedy, who previously served as Sales Director for InspireMD, brings over 30 years of medical device sales leadership experience and will report to CEO Marvin Slosman. Her appointment aligns …

InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing

InspireMD, Inc. has announced the appointment of Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. Kennedy, with over 30 years of medical device sales leadership experience, including in carotid intervention, will report to CEO Marvin Slosman. Her role will be crucial …

Insperity, Inc. Revenue Breakdown – NYSE:NSP

Insperity, Inc. (NYSE: NSP) generated $6.81 billion USD in revenue last year, primarily from its Human Resources and Business Solutions segment, which also accounted for the majority of revenue at $6.81 billion USD. All of the company's revenue came from the United States, showing …

Insperity, Inc. 2026: Revenue $1.69B, EPS $0.1— 10-Q Summary

Insperity, Inc. reported its 2026 quarterly results, with revenue reaching $1.69B and diluted EPS at $0.1. This marks an improvement from the prior year's $1.66B revenue and ($0.14) EPS, with the company returning to a net income of $4M compared to a ($5M) loss …

Inspired Reschedules Its Second Quarter 2026 Results and Conference Call to August 5th

Inspired Entertainment, Inc. has announced a change in the date for its second quarter 2026 results conference call. The company will now report its second quarter results after the market closes on Wednesday, August 5, 2026, with a conference call and webcast scheduled for …

Inspired Entertainment (NASDAQ:INSE) Stock Rating Lowered by Zacks Research

Inspired Entertainment (INSE) Projected to Announce Quarterly Earnings on Thursday

Medical-device sales leader with more than 30 years returns to InspireMD

InspireMD (Nasdaq: NSPR) has appointed Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. Kennedy, with over 30 years of medical device sales leadership, previously supported the U.S. launch of CGuard Prime and returns to help prepare for its potential U.S. commercial …

Hear Inspired Entertainment's Q2 results Aug. 5 at 4:30 p.m.

Inspired Entertainment (NASDAQ: INSE) has rescheduled its Q2 2026 earnings release and conference call to Wednesday, August 5, 2026, after market close. Management will host a webcast and call at 4:30 p.m. ET/9:30 p.m. UK to discuss the results for the quarter ended June …

Insperity Inc (NSP) (Q2 2026) Earnings Call Highlights: Strong EPS Growth Amid Healthcare Cost ...

Insperity (NSP) reported strong Q2 2026 earnings, with adjusted EPS and EBITDA exceeding guidance, alongside outperforming expectations in worksite employee count. The company also highlighted the formal launch of HR Scale and advancing AI strategies, contributing to client confidence. However, year-over-year worksite employee growth …

InspireMD Inc (NSPR) Institutional Confidence

InspireMD Inc (NSPR) has an institutional shareholding score of 3.00, placing it 130th out of 199 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 49.38%, marking a 9.65% decrease quarter-over-quarter. James Simons is the largest institutional shareholder with 32.63K shares, …

Insperity earnings up next: Can it reverse profit slide?

Insperity Inc. is preparing to report its second-quarter earnings, with analysts expecting a significant sequential decline in profitability and revenue. Investors are closely watching for signs that the human-resources services provider can stabilize its profit trajectory, especially given a disappointing first quarter and increasing …

Insperity (NYSE:NSP) Posts Q2 Earnings Beat, Guidance Points to Margin Recovery

Insperity (NYSE:NSP) reported a Q2 earnings beat with adjusted EPS of $0.34, exceeding the $0.32 consensus, though revenue was slightly below expectations. The company provided Q3 and full-year 2026 guidance, with the full-year adjusted EPS midpoint of $2.16 slightly above the current consensus of …

Insperity Q2 net income rises to $4 million as revenue increases 2%

Insperity (NSP) reported a 2% increase in Q2 2026 revenue to $1.686 billion, with net income rising 180% to $4 million. Diluted EPS also saw a significant jump of 171% to $0.10, despite a 1% decrease in average paid worksite employees. The company provided …

Insperity Announces Second Quarter Results

HOUSTON, July 29, 2026--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America's best businesses, today reported results for the second quarter ended June 30, 2026. Insperity will be hosting a conference call today at 5:00 p.m. …

Insperity (NYSE: NSP) returns to Q2 profit and projects 2026 margin recovery

Insperity (NYSE: NSP) reported its Q2 2026 results, showing a return to profit with $4 million in net income and $0.10 diluted EPS, largely due to an 8% reduction in operating expenses. Despite a 1% decline in average paid worksite employees, revenue increased by …

Insperity tops Q2 revenue expectations, shares rise nearly 2%

Insperity (NYSE:NSP) announced second-quarter results that surpassed revenue projections, leading to a 1.7% increase in its stock. The company reported $1.7 billion in revenue, a 2% year-over-year rise, driven by higher pricing and partially offset by a slight decline in worksite employees. Insperity also …

Insperity, Inc. (NSP) Tops Q2 Earnings and Revenue Estimates

Insperity, Inc. (NSP) reported Q2 earnings of $0.34 per share, surpassing the Zacks Consensus Estimate of $0.33, and revenues of $1.69 billion, exceeding the estimate by 0.50%. The company has outperformed the S&P 500 year-to-date with a 35.8% gain. Insperity currently holds a Zacks …

Insperity Jumps 5.7% Amid Sector-Wide Rally

Insperity, Inc. saw a 5.7% increase in its stock price, reaching $55.56 on Wednesday, July 29, 2026, driven by a broad rally across the staffing and employment services sector. This sector-wide momentum also benefited peers like TNET and KFRC, suggesting renewed investor optimism for …

Insperity, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:NSP) 2026-07-29

Insperity, Inc. (NSP) published its Q2 2026 earnings call presentation, reporting an EPS of $0.34, which beat estimates by $0.02. The company also announced revenue of $1.69 billion, surpassing expectations by $14.31 million, representing a 1.69% year-over-year increase. This presentation was released in conjunction …

NSP|Insperity Inc|Price:52.520|Chg%:+1.250

This article provides a comprehensive stock analysis of Insperity Inc (NSP), highlighting its relatively healthy fundamentals, high growth potential, and "fairly valued" status within the Professional & Commercial Services industry. Key insights include high institutional ownership, a "Hold" rating from multiple analysts with a …

Insperity (NYSE:NSP) Surprises With Q2 CY2026 Sales

Insperity (NYSE:NSP) Surprises With Q2 CY2026 Sales HR outsourcing provider Insperity (NYSE:NSP) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 1.7% year on year to $1.69 billion. Its non-GAAP profit of $0.34 per share was 6.9% above analysts' consensus …

Insperity sets 2026 adjusted EBITDA guidance at $185M-$225M

NSP|Insperity Inc|Price:52.570|Chg%:+2.320

This article provides a comprehensive stock analysis of Insperity Inc (NSP), highlighting its relatively healthy fundamentals, high growth potential, and "fairly valued" status within the Professional & Commercial Services industry. Key insights include high institutional ownership, a "Hold" rating from multiple analysts with a …

Insperity Inc (NSP) Risk Assessment: Volatility, Financial Risk & Investment Risk

Insperity Inc (NSP) has a current risk assessment score of 4.73, ranking 94 out of 160 in the Professional & Commercial Services industry, indicating a neutral impact from the U.S. Dollar Index. The company's beta of 0.61 suggests it underperforms in rising markets but …

BlackRock (INSP) reports 4.16M Inspire Medical shares, 14.4% ownership stake

BlackRock, Inc. has filed an amended ownership report, revealing that its reporting business units beneficially own 4,163,016 shares of Inspire Medical Systems, Inc. common stock, which accounts for 14.4% of the outstanding class as of June 30, 2026. BlackRock holds sole voting power over …

BlackRock Inc. (INSE) discloses 6.9% beneficial ownership in Inspired Entertainment

BlackRock, Inc. has filed a Schedule 13G/A, disclosing beneficial ownership of 6.9% of Inspired Entertainment Inc.'s common stock as of June 30, 2026. This equates to 1,834,681 shares, with BlackRock holding sole voting power over 1,808,358 shares and sole dispositive power over all 1,834,681 …

INSPIRE MEDICAL SYSTEMS INC : UBS ASSUMES COVERAGE WITH SELL VS NEUTRAL RATING; TARGET PRICE $39 VS $67

UBS has initiated coverage on Inspire Medical Systems Inc. (INSP.N) with a "Sell" rating, a downgrade from a previous "Neutral" stance. The new target price for the stock is set at $39, significantly lower than the prior $67. This information was reported by Reuters.

UBS Downgrades Inspire Medical Systems to Sell From Neutral, Cuts Price Target to $39 From $67

UBS has downgraded Inspire Medical Systems (NASDAQ: INSP) from Neutral to Sell and significantly cut its price target from $67 to $39. This decision reflects a more cautious outlook on the medical technology company, which specializes in solutions for obstructive sleep apnea. The downgrade …

Insperity (NSP) Reports Q2: Everything You Need To Know Ahead Of Earnings

Insperity (NSP) Reports Q2: Everything You Need To Know Ahead Of Earnings HR outsourcing provider Insperity (NYSE:NSP) will be reporting results this Wednesday after the bell. Here's what investors should know. Insperity met analysts' revenue expectations last quarter, reporting revenues of $1.90 billion, up …

Insperity Inc (NSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Insperity Inc (NSP), detailing its price momentum, support and resistance levels, and the status of various technical indicators and moving averages. The stock's current price momentum score is 4.62, trading between resistance at $54.90 and support at …

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Inspire Medical Systems, Inc. (NYSE: INSP) has announced the appointment of Michael H. Carrel, a veteran medical device executive, to its Board of Directors, effective July 20. Carrel, who has led AtriCure, Inc. as CEO since 2012, brings extensive experience in developing and commercializing …

Inspire Medical Systems (NYSE: INSP) awards 5,631 RSUs to board member Carrel

Inspire Medical Systems (NYSE: INSP) has granted 5,631 restricted stock units (RSUs) to board member Michael H. Carrel. These RSUs vest in three equal annual installments, contingent upon his continued service on the board. Following this award, Carrel directly holds 5,631 RSUs.

Inspire Medical Systems, Inc. (INSP) director files initial Form 3 with no holdings

Inspire Medical Systems, Inc. director Michael H. Carrel has filed an initial Form 3, indicating his new role as a director, but reporting no beneficial share holdings or derivative positions. The filing includes a reference to an Exhibit 24 Power of Attorney. This Form …

NSPR|InspireMD Inc|Price:0.694|Chg%:+0.010

This article provides a detailed company profile for InspireMD Inc (NSPR), a medical device company specializing in MicroNet stent platform technology for vascular and coronary disease treatment. It covers the company's business scope, financial data, market performance, executive team, and institutional shareholding. The key …

Insperity Inc (NSP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Insperity Inc (NSP), noting its current valuation score of 9.20 within the Professional & Commercial Services industry. It states the company's current P/E ratio is -76.38, highlighting a significant deviation from recent highs and lows. The analysis …